title: Infliximab-induced retrobulbar optic neuritis.
authors.affiliation: Livorno Hospital, Livorno, Italy. nimumoli@tiscali.it
authors.forename: N
authors.initials: N
authors.lastname: Mumoli
authors.forename: G
authors.initials: G
authors.lastname: Niccoli
authors.forename: F
authors.initials: F
authors.lastname: Scazzeri
authors.forename: S
authors.initials: S
authors.lastname: Picchietti
authors.forename: A
authors.initials: A
authors.lastname: Greco
authors.forename: M
authors.initials: M
authors.lastname: Cei
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D005682:Gadolinium; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D009902:Optic Neuritis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D011239:Prednisolone; D005682:Gadolinium; D000069285:Infliximab